deltaDOT is a spin out company from Imperial College London UK - a team of scientists and
engineers dedicated to the advancement of analytical techniques using patented methods and
instrumentation in High Performance Capillary Electrophoresis (HPCE). Our offices and
laboratories are based in the London Bioscience Innovation Centre (LBIC).
engineers dedicated to the advancement of analytical techniques using patented methods and
instrumentation in High Performance Capillary Electrophoresis (HPCE). Our offices and
laboratories are based in the London Bioscience Innovation Centre (LBIC).
Who we are
HPCE instruments
PEREGRINE I is the first High Performance Capillary Electrophoresis (HPCE) product
launched by deltaDOT. It uses deltaDOT’s proprietary imaging and analysis technology, Label
Free Intrinsic Imaging (LFII®), applied to a CE system. PEREGRINE I offers dramatically
improved discovery power in comparison to other conventional CE systems.
launched by deltaDOT. It uses deltaDOT’s proprietary imaging and analysis technology, Label
Free Intrinsic Imaging (LFII®), applied to a CE system. PEREGRINE I offers dramatically
improved discovery power in comparison to other conventional CE systems.
deltaDOT team of scientists has developed considerable expertise in CE based analysis and in
solving clients’ analytical problems. Using our own HPCE LFII™ analytical instruments we
offer Analytical Services and Contract Research to industry and academia from our
laboratories in the London Bioscience Innovation Centre.
solving clients’ analytical problems. Using our own HPCE LFII™ analytical instruments we
offer Analytical Services and Contract Research to industry and academia from our
laboratories in the London Bioscience Innovation Centre.
Analytical Services
& Contract Research
HPCE Applications
High Performance Capillary Electrophoresis is applied in Life Sciences research, drug testing,
diagnostics and bio-pharmaceutical manufacturing. This technology is used in detection,
separation and analysis of proteins, nucleic acids, carbohydrates, viruses and bacteria,
chemicals and a wide range of other analytes. More detail can be found on our Technology
pages.
diagnostics and bio-pharmaceutical manufacturing. This technology is used in detection,
separation and analysis of proteins, nucleic acids, carbohydrates, viruses and bacteria,
chemicals and a wide range of other analytes. More detail can be found on our Technology
pages.
Application Notes
& Downloads
Antibody Analysis, Viral Titre, Amino Acid Analysis, Fatty Acids, Transferrin, Small Molecules,
Peptides, Complex Protein Lysate, Recombinant Human Erythropoietin, Antibiotics in food
products, Cell Lysate, Glycoforms, DNA, RNA, Chemicals, Baculovirus Titre.
Peptides, Complex Protein Lysate, Recombinant Human Erythropoietin, Antibiotics in food
products, Cell Lysate, Glycoforms, DNA, RNA, Chemicals, Baculovirus Titre.
13 August 2012 Texas A&M System Awarded National Center for
Innovation
deltaDOT Ltd. is a partner in BARDA funded international
consortium
$285.6 million public-private partnership to enhance the nation’s
biosecurity preparedness and create jobs in Texas
COLLEGE STATION, Texas – John Sharp, chancellor of The Texas
A&M University System, today announced that the A&M System
has been awarded a contract to develop one of three U.S.
Department of Health and Human Services Centers for
Innovation in Advanced Development and Manufacturing. The
$285.6 million contract includes an initial investment of $176.6
million from the U.S. government, with the remainder cost-
shared by commercial and academic proposal partners.
2nd August 2012 deltaDOT Ltd. awarded Technology Strategy
Board grant
deltaDOT Ltd, announced today that the government-backed
Technology Strategy Board has awarded the company a feasibility
study award for the applicationof its Label Free Intrinsic Imaging
technology to bioprocess analytics. The project “Rapid low cost
formulation screening for protein self-interaction based on High
Performance Capillary Electrophoresis” is a feasibility study that
addresses the need for a costeffective,
user-friendly, automated platform technology allowing rapid
screening for protein selfinteractions.
A&M University System, today announced that the A&M System
has been awarded a contract to develop one of three U.S.
Department of Health and Human Services Centers for
Innovation in Advanced Development and Manufacturing. The
$285.6 million contract includes an initial investment of $176.6
million from the U.S. government, with the remainder cost-
shared by commercial and academic proposal partners.
2nd August 2012 deltaDOT Ltd. awarded Technology Strategy
Board grant
deltaDOT Ltd, announced today that the government-backed
Technology Strategy Board has awarded the company a feasibility
study award for the applicationof its Label Free Intrinsic Imaging
technology to bioprocess analytics. The project “Rapid low cost
formulation screening for protein self-interaction based on High
Performance Capillary Electrophoresis” is a feasibility study that
addresses the need for a costeffective,
user-friendly, automated platform technology allowing rapid
screening for protein selfinteractions.
LABEL FREE
INTRINSIC
IMAGING
LFII®